RE:Zenabis Global closes public offering at 0.085 for $7.02M+ ZENABIS closes $8.07-million bought deal
ZENABIS SET TO ANNOUNCE CLOSING OF OVERSUBSCRIBED BOUGHT DEAL FINANCING
Zenabis has closed its previously announced short form prospectus offering, on a bought deal basis, including the full exercise of the underwriters' overallotment option.
Closing this financing is a very important inflection point for Zenabis as they continue global expansion plans. The capital raised from this bought deal allows Zenabis to reduce debt, while increasing distribution networks which will add value for shareholders. Zenabis is excited to further execute on their growth strategy.